Q4 2012 13F Holders as of 31 Dec 2012
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Shares outstanding
-
1,148,777,709
-
Total 13F shares
-
1,357,724
-
Share change
-
-347,466
-
Total reported value
-
$50,695,276
-
Put/Call ratio
-
82%
-
Price per share
-
$37.34
-
Number of holders
-
12
-
Value change
-
-$14,030,437
-
Number of buys
-
6
-
Number of sells
-
3
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) as of Q4 2012
As of 31 Dec 2012,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,357,724 shares.
The largest 10 holders included
AGF Investments America Inc., HUNTINGTON NATIONAL BANK, Glenview Trust Co, MUFG Americas Holdings Corp, HUNTINGTON ASSET ADVISORS, INC., Zurcher Kantonalbank (Zurich Cantonalbank), Northwest & Ethical Investments L.P., Baskin Financial Services Inc., Veritable, L.P., and Twin Tree Management, LP.
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2012 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.